Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

IndustryWeek June 23, 2010	By The Numbers -- The Expense of R&D Among U.S.-owned businesses and U.S. affiliates of foreign companies, much of the R&D remained in the United States.
IndustryWeek November 3, 2009	Benchmarking R&D Top innovators increased their research-and-development spending even as the economy sank, according to the Booz & Co. fifth annual analysis of global innovation spending.
IEEE Spectrum December 2007 Hira & Ross	The R&D 100 A company's research budget tells you very little about its prospects.
IndustryWeek April 1, 2005 Patricia Panchak	Editor's Page -- Playing The R&D Blame Game The Bush Administration's 2006 budget short-changes industrial research and development. Industry executives and shareholders have also contributed to a slowing of spending on basic research.
IndustryWeek October 20, 2010	Innovation Nation? Manufacturers are more involved than other industries in innovation, but engagement is hardly widespread.
InternetNews June 15, 2006 Michael Hickins	Open Source Is a Model For Innovation IBM offers consulting help for R&D organizations hoping to have a greater impact on innovation.
InternetNews November 30, 2006 Paul Shread	Au Revoir, Bell Labs Bell Labs, the 81-year-old crown jewel of American technological innovation, is now part of a French company... Stocks were mixed... Digital Insight surged on a buyout deal with Intuit... etc.
IndustryWeek June 1, 2004 John Teresko	Open Innovation? Rewards And Challenges Open Innovation is a strategy of finding and bringing in new ideas that are complementary to existing research & development projects. But open innovation does not just happen. It requires changes in corporate culture and must be driven from the top.
IEEE Spectrum December 2005 Hira & Goldstein	R&D 100 Automakers top the list, drug companies trim back, and telecoms continue to gut their research budgets.
The Motley Fool April 19, 2004 Ben McClure	Ruminations on R&D Spending on research and development is important. But can it help identify promising investments? It's pretty easy to spot companies that spend a lot of money on R&D. It's another thing to pick companies that translate R&D spending into higher stock prices.
IndustryWeek January 1, 2008 Jill Jusko	By What Measure? Research and development efforts cost plenty. Gauging their effectiveness, though, remains a challenge.
Fast Company December 2004 Carleen Hawn	Lessons on Innovation From Microsoft There are plenty of internal reasons why Microsoft's record of innovation is so lackluster. But the company's failure also points to three much bigger lessons about innovation.
IndustryWeek January 1, 2009 Jill Jusko	R&D Spending: By the Numbers While the software industry spends 13.6% on R&D as a percentage of sales, the chemicals and energy sector spends only 1%.
Chemistry World October 26, 2011 Maria Burke	Europe risks being outstripped by R&D rivals EU companies are lagging behind in R&D investment compared with major competitors from the US and some Asian economies, according to the European Commission's 2011 EU Industrial R&D Investment Scoreboard.
The Motley Fool July 30, 2004 Chris Mallon	Adjusting for Innovation If research and development is an investment, why not treat it as such? While not necessarily cheap, tech companies don't appear quite so overvalued when you adjust for investment in innovation.
The Motley Fool February 26, 2010 Brian Orelli	Drug Company Cost Cuts: Careful What You Wish For Research and development is the lifeblood of future revenue.
HBS Working Knowledge March 20, 2006 Huston & Sakkab	P&G's New Innovation Model Procter & Gamble's assessment of its aging innovation process and the development of connect and develop.
Pharmaceutical Executive January 21, 2014 Tim Powell	Innovation: The Moneyball Test Successful innovation now has to align with key metrics of value; can an old baseball metaphor help guide the way?
The Motley Fool January 19, 2007 Selena Maranjian	In R&D, China Is No. 2 China passes Japan in research and development spending. What does this mean to investors?
InternetNews May 12, 2004 Roy Mark	Lieberman Raps Parties Over Offshoring Unless policymakers find middle ground between free trade and protectionism, high-end IT jobs will be next to go, the senator says.
IndustryWeek August 1, 2003 John Teresko	Technology Brokering, An R&D Checklist List offers ways to convert R&D laboratories into technology brokers.
Chemistry World December 10, 2012 Andrew Turley	EU companies increasing R&D Companies in the EU are increasing their investment in R&D, despite the difficult economic conditions, according to a report from the European Commission that looked at the global top 1500 R&D investors.
Pharmaceutical Executive June 1, 2005 Jan Malek	When Two Heads are Better R&D president isn't one job-it's two. By appointing COOs for R&D with broad operational mandates, biotech and pharmaceutical companies can ensure that operational issues get the attention they urgently require.
IndustryWeek December 1, 2008 Jill Jusko	Hey Big (R&D) Spenders Top corporate spenders in R&D spend nearly half a trillion dollars in 2007.
Bio-IT World December 10, 2002 Jim Hall	21st Century R&D Strategy: Atlantic or Pacific? The biopharmaceutical sector is divided by two strategic perspectives.
IndustryWeek March 1, 2005 Patricia Panchak	Editor's Page -- Profit Pursuits Are Choking Innovation A lot of people -- from business leaders, academics, think-tank researchers and government officials -- are worried about the U.S.' innovation infrastructure. Will a short-term focus set us up for a fall?
The Motley Fool July 27, 2011 Michael Olsen	Rising Stars Buy: Icon Icon, the fourth-largest CRO, sits among the global elite and makes for a healthy investment.
IndustryWeek December 1, 2004 John Teresko	Technology Leader Of The Year -- P&G's Secret: Innovating Innovation In 2000, the CTO of America's biggest consumer packaged goods company began his technology and innovation driven transformation of what some called a stodgy 167-year old Midwestern giant. Now, he's been acknowledged as its "technical innovation leader" by the company's CEO.
IndustryWeek December 1, 2007 Jill Jusko	Hey Big Spender: By the Numbers A look at R & D spending in 2006.
HBS Working Knowledge September 19, 2012 Carmen Nobel	Funding Innovation: Is Your Firm Doing it Wrong? Many companies are at a loss about how to fund innovation successfully. In his new book, The Architecture of Innovation, Professor Josh Lerner starts with this advice: get the incentives right.
The Motley Fool September 10, 2008 Brian Orelli	Are Drug Companies Being Shortsighted With R&D? Cutting research and development spending could be like playing with fire for pharmaceutical companies.
The Motley Fool June 24, 2010 Luke Timmerman	Amylin Cuts 60 Jobs The pharmaceutical company says research is still a priority.
HBS Working Knowledge October 17, 2012	Why America Needs a Manufacturing Renaissance In their new book, Producing Prosperity: Why America Needs a Manufacturing Renaissance, Pisano and Shih discuss the dangers of underinvesting in the nation's manufacturing capabilities.
Information Today August 11, 2015	Thomson Reuters Rolls Out Pharmaceutical R&D Factbook The 2015 CMR International Pharmaceutical R&D Factbook shows global R&D trends for the biopharmaceutical industry.
The Motley Fool February 9, 2010 Selena Maranjian	Do Patents Lead to Profits? A pile of intellectual property helps -- but it's not enough. Companies that break rules and devise new ways of doing things can create entire new industries.
Pharmaceutical Executive September 1, 2012 Roy F. Waldron	Open Innovation in Pharma: Defining the Dialogue There is much talk today about "open innovation" in business and research forums, but what exactly does it mean? How does open innovation as a concept apply to the pharmaceutical sector?
The Motley Fool March 15, 2004 Ben McClure	More R&D, Please Big tech players up the research and development ante.
Chemistry World November 24, 2015 Rebecca Trager	US universities face federal R&D funding fall American universities experienced a continuing decline in federal research and development funding in fiscal year 2014, according to new data from the US National Science Foundation.
IndustryWeek July 22, 2009 Josh Cable	Holding the Line on R&D Through steady commitment to R&D and careful scrutiny of projects' objectives, manufacturers such as Parker Hannifin and Texas Instruments are ensuring that innovation doesn't become a victim of the economic downturn.
Pharmaceutical Executive September 1, 2010	Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development.
BusinessWeek August 27, 2009 Adrian Slywotzky	How Science Can Create Millions of New Jobs Reigniting basic research can repair the broken U.S. business model and put Americans back to work.
The Motley Fool June 5, 2007 Toby Shute	Quick Take: Revved-Up Auto Sales Auto manufacturers had a great month, with one glaring exception. Do Ford's investors need shock absorbers? They shouldn't -- the auto maker's results should really not surprise anyone.
Chemistry World November 21, 2014 Rebecca Trager	China poised to become top science spender China is on track to become the world's top R&D spender before the end of the decade, according to a new report released by the Organization for Economic Cooperation and Development.
The Motley Fool April 5, 2005 Stephen D. Simpson	Pfizer Pfaces Its Pfuture Analysts and investors seem happy with Pfizer's long-term strategy. Should they be?
IEEE Spectrum February 2007 Stephen Cass	Where the Jobs Are A survey of 752 IEEE members about the past, present, and future technological trends. Overall, the news is encouraging for the tech industry, albeit not spectacular.
Pharmaceutical Executive September 1, 2005 Parker & Amar	Building Blockbusters The most lucrative new drugs are often less glamorous than first-in-class new molecular entities. And they are much less risky.
Prepared Foods June 1, 2005 Terry J. Schwartz	Extra Credit Many food processing companies lose significant amounts of cash each year by not claiming the Research and Development tax credit -- yet the food industry is rich in R&D, and qualifying R&D activities are pervasive.
IndustryWeek December 1, 2005 John Teresko	IBM, R&D And 60 Years When analysts noted in October that IBM's third quarter exceeded expectations, most merely referred to the strength of the business model across hardware, software and services. But they missed a few R&D points.
IndustryWeek May 1, 2008 John Teresko	The Future of R&D: Leveraging Innovation Contrary to conventional thinking, R&D is a very manageable driver of corporate success.
The Motley Fool August 4, 2009 Tim Beyers	Does the President Want You to Buy This Stock? Which company is likeliest to produce the innovation of which the president spoke recently? Take a look at why IBM may be the stock for the future.